Combination of Cytokine-Induced Killer Cells and Programmed Cell Death-1 Blockade Works Synergistically to Enhance Therapeutic Efficacy in Metastatic Renal Cell Carcinoma and Non-Small Cell Lung Cancer

INTRODUCTION: Programmed cell death-1 (PD-1) inhibition therapy has changed the treatment paradigm of metastatic renal cell carcinoma (MRCC) and non-small cell lung cancer (NSCLC). However, attempts to use the drug as a single agent have achieved only limited clinical success. To further enhance the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zibing, Liu, Xiaoli, Till, Brian, Sun, Miaomiao, Li, Xiang, Gao, Quanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041387/
https://www.ncbi.nlm.nih.gov/pubmed/30026742
http://dx.doi.org/10.3389/fimmu.2018.01513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041387/
https://www.ncbi.nlm.nih.gov/pubmed/30026742
http://dx.doi.org/10.3389/fimmu.2018.01513

Ejemplares similares